EZH2 and meningioma: The data presented here provide the first evidence that EZH2 overexpression is associated with an unfavorable outcome and higher proliferative activity as well as with 9p21.3 deletion and loss of H3 K27me3 in CNS WHO grade 3 meningiomas.